The disease manifestations in HTLV-I (human T-cell lymphotropic virus)-infected individuals are highly diverse, ranging from malignancies to autoimmune-like diseases. Since no differences in virus structure or function have been found in isolates from individuals with the various diseases, differences in disease manifestation may reside in the cell targeted for infection and/or the host's response to infection. The cell infected in vivo with HTLV-I or HTLV-II (a virus similar to HTLV-I; however, with no disease associations) was identified in subpopulations of peripheral blood lymphocytes separated on the basis of cell surface markers. The CD4+ and CD8+ cells were infected with virus in HTLV-I-positive individuals; however, virus expression was found to be predominant in CD4+ cells. In HTLV-II-infected individuals, provirus and expressed virus were found in CD+8 cells and occasionally in CD4+ cells. A disease manifestation of HTLV-I infection in childhood is infectious dermatitis. Distribution of peripheral blood T-cell subsets with and without activation markers were compared in HTLV-I-infected and noninfected children. Increased numbers of activated CD4+ cells were found in infected children that were positively correlated with duration of infection.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CP005328-13
Application #
5201475
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
United States
Zip Code